Safety and efficacy of miltefosine in cutaneous leishmaniasis: An open label, non-comparative study from Balochistan

BACKGROUND & OBJECTIVE: Cutaneous Leishmaniasis (CL) is endemic in Baluchistan and treated traditionally with Meglumine antimoniate. Miltefosine appears appealing therapy in cutaneous Leishmaniasis. Our objective was to evaluate safety and efficacy of Miltifossine in treatment of cutaneous Leish...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahir, Moizza, Bashir, Uzma, Hafeez, Javeria, Ghafoor, Rabia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500830/
https://www.ncbi.nlm.nih.gov/pubmed/31086539
http://dx.doi.org/10.12669/pjms.35.2.54

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500830/
https://www.ncbi.nlm.nih.gov/pubmed/31086539
http://dx.doi.org/10.12669/pjms.35.2.54

Ejemplares similares